These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26786165)

  • 1. Notch1 deficiency decreases hepatic lipid accumulation by induction of fatty acid oxidation.
    Song NJ; Yun UJ; Yang S; Wu C; Seo CR; Gwon AR; Baik SH; Choi Y; Choi BY; Bahn G; Kim S; Kwon SM; Park JS; Baek SH; Park TJ; Yoon K; Kim BJ; Mattson MP; Lee SJ; Jo DG; Park KW
    Sci Rep; 2016 Jan; 6():19377. PubMed ID: 26786165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimethylarginine Dimethylaminohydrolase 1 Protects Against High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance in Mice.
    Li T; Feng R; Zhao C; Wang Y; Wang J; Liu S; Cao J; Wang H; Wang T; Guo Y; Lu Z
    Antioxid Redox Signal; 2017 Apr; 26(11):598-609. PubMed ID: 27565538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DJ-1 Deficiency Protects Hepatic Steatosis by Enhancing Fatty Acid Oxidation in Mice.
    Xu M; Wu H; Li M; Wen Y; Yu C; Xia L; Xia Q; Kong X
    Int J Biol Sci; 2018; 14(13):1892-1900. PubMed ID: 30443192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
    Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
    Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenteric Fat Lipolysis Mediates Obesity-Associated Hepatic Steatosis and Insulin Resistance.
    Wueest S; Item F; Lucchini FC; Challa TD; Müller W; Blüher M; Konrad D
    Diabetes; 2016 Jan; 65(1):140-8. PubMed ID: 26384383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of microRNA-125a contributes to obesity-associated insulin resistance and dysregulates lipid metabolism in mice.
    Liu R; Wang M; Li E; Yang Y; Li J; Chen S; Shen WJ; Azhar S; Guo Z; Hu Z
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 May; 1865(5):158640. PubMed ID: 31988048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin suppresses Notch‑1 signaling: Improvements in fatty liver and insulin resistance in rats.
    Zhao NJ; Liao MJ; Wu JJ; Chu KX
    Mol Med Rep; 2018 Jan; 17(1):819-826. PubMed ID: 29115530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.
    Geisler CE; Renquist BJ
    J Endocrinol; 2017 Jul; 234(1):R1-R21. PubMed ID: 28428362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
    Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mitochondrial β-oxidation by miR-107 promotes hepatic lipid accumulation and impairs glucose tolerance in vivo.
    Bhatia H; Pattnaik BR; Datta M
    Int J Obes (Lond); 2016 May; 40(5):861-9. PubMed ID: 26499439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
    Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
    Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cideb regulates diet-induced obesity, liver steatosis, and insulin sensitivity by controlling lipogenesis and fatty acid oxidation.
    Li JZ; Ye J; Xue B; Qi J; Zhang J; Zhou Z; Li Q; Wen Z; Li P
    Diabetes; 2007 Oct; 56(10):2523-32. PubMed ID: 17646209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic Notch1 deletion predisposes to diabetes and steatosis via glucose-6-phosphatase and perilipin-5 upregulation.
    Bernsmeier C; Dill MT; Provenzano A; Makowska Z; Krol I; Muscogiuri G; Semela D; Tornillo L; Marra F; Heim MH; Duong FH
    Lab Invest; 2016 Sep; 96(9):972-80. PubMed ID: 27428080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation.
    Orellana-Gavaldà JM; Herrero L; Malandrino MI; Pañeda A; Sol Rodríguez-Peña M; Petry H; Asins G; Van Deventer S; Hegardt FG; Serra D
    Hepatology; 2011 Mar; 53(3):821-32. PubMed ID: 21319201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JNK Activation of BIM Promotes Hepatic Oxidative Stress, Steatosis, and Insulin Resistance in Obesity.
    Litwak SA; Pang L; Galic S; Igoillo-Esteve M; Stanley WJ; Turatsinze JV; Loh K; Thomas HE; Sharma A; Trepo E; Moreno C; Gough DJ; Eizirik DL; de Haan JB; Gurzov EN
    Diabetes; 2017 Dec; 66(12):2973-2986. PubMed ID: 28928277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavangenol (pine bark extract) and its major component procyanidin B1 enhance fatty acid oxidation in fat-loaded models.
    Shimada T; Tokuhara D; Tsubata M; Kamiya T; Kamiya-Sameshima M; Nagamine R; Takagaki K; Sai Y; Miyamoto K; Aburada M
    Eur J Pharmacol; 2012 Feb; 677(1-3):147-53. PubMed ID: 22227333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between aquaglyceroporin expression and development of fatty liver in diet-induced obesity and ob/ob mice.
    Hirako S; Wakayama Y; Kim H; Iizuka Y; Matsumoto A; Wada N; Kimura A; Okabe M; Sakagami J; Suzuki M; Takenoya F; Shioda S
    Obes Res Clin Pract; 2016; 10(6):710-718. PubMed ID: 26747210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.